XML 66 R56.htm IDEA: XBRL DOCUMENT v3.22.4
Equity - Stock Option Activity (Details)
$ / shares in Units, shares in Thousands, $ in Thousands
 9 Months Ended 12 Months Ended
Dec. 31, 2022
USD ($)
$ / shares
shares
Mar. 31, 2022
USD ($)
$ / shares
shares
Number of Shares (in thousands)    
Beginning balance (in shares) | shares 26,983  
Options exercised (in shares) | shares (2,659)  
Options forfeited or expired (in shares) | shares (446)  
Ending balance (in shares) | shares 23,878 26,983
Vested and exercisable, at end of period (in shares) | shares 11,697  
Vested and expected to vest, at end of period (in shares) | shares 22,476  
Weighted-Average Exercise Price    
Beginning balance (in dollars per share) | $ / shares $ 4.15  
Exercised (in dollars per share) | $ / shares 2.77  
Forfeited or expired (in dollars per share) | $ / shares 5.62  
Ending balance (in dollars per share) | $ / shares 4.27 $ 4.15
Weighted average exercise price, vested and exercisable at period end (in dollars per share) | $ / shares 2.35  
Weighted average exercise price, vested and expected to vest at period end (in dollars per share) | $ / shares $ 4.19  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]    
Average remaining contractual term, outstanding 6 years 11 months 12 days 7 years 7 months 17 days
Average remaining contractual term, vested and exercisable at period end 5 years 11 months 19 days  
Average remaining contractual term, vested and expected to vest at period end 6 years 10 months 20 days  
Aggregate intrinsic value, outstanding | $ $ 699,367 $ 1,293,545
Aggregate intrinsic value, vested and exercisable at period end | $ 365,043  
Aggregate intrinsic value, vested and expected to vest at period end | $ $ 660,023